2. Renal calculus 1

3. 2

4. Types of renal calculi 1.Primary 2.Secondary 3

5. Primary renal stones These are found in healthy urinary tract Usually form in acidic urine Common types: – Oxalate calculus (calcium oxalate) – Uric acid & urate calculi – Cystine calculi – Xanthine calculi 4

6. Secondary renal stones These are found in inflammed urinary tract Usually form in alkaline urine Common types: struvite stones 5

7. Stone pathogenesis ❏ factors promoting stone formation stasis (hydronephrosis, congenital abnormality) medullary sponge kidney infection (struvite stones) hypercalciuria increased oxalate increased uric acid ❏ loss of inhibitory factors magnesium (forms soluble complex with oxalate) citrate (forms soluble complex with calcium) pyrophosphate glycoprotein 6

8. Calcium stones ❏ account for 80 - 85% of all stones ❏ Ca2+ oxalate most common, followed by Ca2+ phosphate description grey or brown due to hemosiderin from bleeding radiopaque 7

9. Etiology Hypercalciuria Hyperuricosuria Hypocitraturia Hyperoxaluria 8

10. ❏ hypercalciuria (60-70% of patients) 95% of these patients have normal serum calcium levels 5-10% of people without stones have hypercalciuria absorptive causes (majority of patients) increased vitamin D sensitivity ––> idiopathic 9

11. ❏ hyperuricosuria (25% of patients with Ca2+ stones) uric acid becomes insoluble at pH of < 5.8 uric acid acts as nidus for Ca2+ stone formation by constantly acidic urine, dehydration, or both treatment add allopurinol if uric acid excretion > 5 mmol/day 10

12. ❏ hypocitraturia (12% of patients) associated with type I RTA or chronic thiazide use treatment potassium citrate 11

13. ❏ hypercalcemia (5% of patients) primary hyperparathyroidism malignancy sarcoidosis increased vitamin D hyperthyroidism milk-alkali syndrome 90% of cases 12

14. ❏ hyperoxaluria (< 5% of patients) insoluble end product of metabolism enteric hyperoxaluria (patients with malabsorption) inflammatory bowel disease (IBD) short bowel syndrome exogenous causes dietary increase (caffeine, potatoes, rhubarb, chocolate, vitamin C) primary increase in endogenous production (rare autosomal recessive disorder) treatment increase water intake, avoid oxalate-containing foods oral calcium or cholestyramine 13

15. Uric Acid Stones ❏ account for 10% of all stones ❏ description and diagnosis orange coloured gravel, needle shaped crystals radiolucent on x-ray filling defect on IVP radiopaque on CT scan visualized with ultrasound ❏ etiology hyperuricosuria (urine pH < 5.5) secondary to increased uric acid production, or drugs hyperuricemia gout myeloproliferative disease cytotoxic drugs defect in tubular NH3 synthesis (ammonia trap for H+) dehydration, IBD, colostomy and ileostomy 14

16. ❏ treatment increase fluid intake NaHCO3 (maintain urinary pH no less than 6.5) allopurinol avoid high protein/ purine diet 15

17. Cystine stones ❏ autosomal recessive defect in small bowel mucosal absorption and renal tubular absorption of dibasic amino acids ❏ seen in children and young adults ❏ aggressive stone disease 16

18. ❏ description hexagonal on urinalysis yellow, hard radiopaque (ground glass) staghorn or multiple decreased reabsorption cystine (insoluble in urine); ornithine, lysine, arginine (soluble in urine) 17

19. ❏ diagnosis amino acid chromatography of urine ––> see COLA in urine serum cystine Na+ nitroprusside test 18

20. ❏ treatment greatly increase water intake ––> 3-4 L urine/day HCO3– decrease dietary protein ––> methionine penicillamine chelators ––> 2 g daily, soluble complex formed; use cautiously a- mercaptopropionylglycine (MPG) ––> similar action to penicillamine, less toxic captopril (binds cystine) irrigating solutions: N- acetylcystine (binds cystine), Tromethamine-E 19

21. Struvite Stones ❏ female patients affected twice as often as male patients ❏ etiology and pathogenesis account for 10% of all stones contribute to formation of staghorn calculi consist of triple phosphate (calcium, magnesium, ammonium) due to infection with urea splitting organisms NH2CONH2 + H2O ––> 2NH3 + CO2 NH4 alkalinizes urine, thus decreasing solubility 20

22. ❏ common organisms Proteus Klebsiella Pseudomonas Provididencia S. aureus not E. coli 21

23. 22

24. ❏ treatment complete stone clearance (ESWL/percutaneous nephrolithotomy) acidify urine, dissolve microscopic fragments antibiotics for 6 weeks follow up urine cultures 23

25. Effects of stone Same kidney: Obstruction: hydronephrosis renal failure Infection: pyelonephritis Local ischemia Malignancy Opposite kidney: Compensatory hypertrophy Stone formation Infection Calculus anuria: due to reno - renal reflex

26. Clinical features Quiescent calculus Pain Hydronephrosis Hematuria

27. Quiescent calculus Mainly the phosphate stones

28. Pain Fixed renal pain Ureteric colic Referred pain

29. Signs Tenderness Muscle rigidity Swelling

30. Tenderness Mainly in the renal angle Renal angle: the angle between the lower border of the 12 th rib & the lateral border of the erector spinae muscles

31. 30

32. Investigations Blood Urine X –ray KUB: 90% of the renal stones are radio – opaque Excretory urograms Ultrasonography Renal scan

33. Treatment Conservative Percutaneous methods: – Percutaneous nephrolithotomy (PCNL) – Extracorporeal shock wave lithotripsy (ESWL) – Ureteroscopy (URS) Surgery: – Pyelolithotomy – Nephrolithotomy – Partial nephrectomy – Nephrectomy

34. Differential Diagnosis of Renal Colic ❏ other causes of acute ureteral obstruction UPJ obstruction sloughed papillae clot colic from gross hematuria ❏ gynecological causes (ectopic preganancy, torsion of ovary cyst) ❏ radiculitis (L1 nerve root irritation) herpes zoster nerve root compression ❏ pyelonephritis (fever, chills, pyuria) ❏ acute abdominal crisis (biliary, bowel) ❏ leaking abdominal aortic aneurysm 33

35. Location of Stones ❏ calyx may cause flank discomfort, recurrent infection or persistent hematuria may remain asymptomatic for years and not require treatment ❏ pelvis tend to cause UPJ obstruction renal pelvis and one or more calyces staghorn calculi often associated with infection infection will not resolve until stone cleared may obstruct renal drainage ❏ ureter < 5 mm diameter will pass spontaneously in 75% of patients the three narrowest passage points for upper tract stones include: UPJ, pelvic brim, UVJ 34

36. R elationship of Stone Location to Symptoms

37. Stone Location Common Symptom Kidney Vague Flank Pain, Hematuria

38. Stone Location Common Symptom Proximal Ureter Renal colic, flank pain, upper abdominal pain R elationship of Stone Location to Symptoms

39. Stone Location Common Symptom Middle section of Renal colic, anterior ureter abdominal pain, flank pain R elationship of Stone Location to Symptoms

40. Stone Location Common Symptom Distal ureter Renal colic, dysuria, urinary frequency, anterior abdominal pain, flank pain

41. Acute Management ❏ medical analgesic NSAIDs help lower intra-ureteral pressure +/– antibiotics for UTI IV fluids if vomiting ❏ indications for admission to hospital severe persistent pain uncontrolled by oral analgesics fever ––> infection high grade obstruction single kidney with ureteral obstruction bilateral ureteral stones persistent vomiting ❏ surgical ureteric stent high grade obstruction single kidney ❏ radiological percutaneous nephrostomy (alternative to stent) 40

42. Elective Management ❏ medical conservative if stone < 5 mm and no complications alkalinization of uric acid and cystine stones may be attempted (potassium citrate) patient must receive one month of therapy before being considered to have failed 41

43. Elective Management ❏ surgical kidney extracorporeal shock wave lithotripsy (ESWL) if stone < 2.5 cm, + stent if 1.5-2.5 cm percutaneous nephrolithotomy stone > 2.5 cm staghorn UPJ obstruction calyceal diverticulum cystine stones (poorly fragmented with ESWL) open nephrolithotomy extensively branched staghorn 42

44. Elective Management ❏ surgical ureter ESWL is primary modality of treatment Ureteroscopy failed ESWL highly efficacious for lower ureteral calculi ureteric stricture reasonable alternative for distal 1/3 of ureter open ureterolithotomy rarely necessary (failed ESWL and ureteroscopy) 43

45. ESWL 44

46. 45

47. 46 Percutaneous nephrolithotomy